Search results for "44"

showing 10 items of 1507 documents

Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program

2018

To analyze the results of sentinel patient program to monitoring the  quality pharmacoterapeutic process in the hospitalized patient through  medication errors.Design: Observational, prospective and transversal study. Ambit: General hospital of 1,000 beds.From May 2011 to June 2016.  Sample: Patients with treatment prescribe within 24 hours of being admitted  with 4 or more medications.Medication error, drugs prescribed,  medications and doses dispensing, drugs administered. Safety indicators were  defined based on medication errors at each stage of the pharmacotherapeutic  process.Of the 746 patients studied, 334 had at least 1 medication error  (44.8%; IC95%: 41.7-47.8). In the 746 treatm…

lcsh:Rlcsh:Medicinelcsh:RS1-441Safety;Drug PrescriptionsQuality ImprovementDrug Hypersensitivitylcsh:Pharmacy and materia medicaMedication errorsQuality monitoringHumansPatient SafetyProspective StudiesSafetyPharmacy Service HospitalQuality of Health CareFarmacia Hospitalaria
researchProduct

Inhibition of Saccharomyces cerevisiae Pdr5p by a natural compound extracted from Brazilian Red Propolis

2011

Multidrug resistance of cancer cells and pathogenic microorganisms leading to the treatment failure of some forms of cancer or life-threatening bacterial or fungal infections is often caused by the overexpression of multidrug efflux pumps belonging to the ATP-binding cassette transporters superfamily. The multidrug resistance of fungal cells often involves the overexpression of efflux pumps belonging to the pleiotropic drug resistance (PDR) family of ABC transporters. Possibly the best-studied fungal PDR transporter is the multidrug resistance transporter Pdr5p of Saccharomyces cerevisiae. Some research groups have been searching for new inhibitors of these efflux pumps in order to alleviat…

lcsh:RS1-441Biological activityATP-binding cassette transporterDrug resistancePropolisBiologyYeastMultiple drug resistanceFungicidelcsh:Pharmacy and materia medicaBiochemistryBrazilian Red Propolis multidrug resistance Pdr5p R6G yeastEffluxGeneral Pharmacology Toxicology and Pharmaceutics
researchProduct

Recycling of almond by-products for intestinal inflammation: improvement of physical-chemical, technological and biological characteristics of a drie…

2020

Background: Almond skins are rich in bioactive compounds that undergo oxidation/degradation phenomena and are poorly soluble in water, reducing in vivo absorption and bioavailability, factors that influence the pharmacological activity of an active product. We developed a dried acetonic almond skins extract/cyclodextrin complex to improve extract solubility, dissolution rate and biological activity. Methods: A lyophilized acetonic almond skin extract was produced. To optimize complex formulation, phase solubility studies and complex characterization (absorption studies, differential scanning calorimetry (DSC), morphology, solubility studies) were performed. To evaluate a possible use in hea…

lcsh:RS1-441Pharmaceutical ScienceAbsorption (skin)Articlelcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDifferential scanning calorimetrycatechinAlmond extractoxidative stressSolubilityDissolutionsolubility studies030304 developmental biologychemistry.chemical_classification0303 health sciencesChromatographyCyclodextrinfood and beveragesCatechinBiological activitycomplex characterizationBioavailabilityAlmond extract; cyclodextrin; catechin; solubility studies; complex characterization; intestinal epithelial cells; inflammation; oxidative stresschemistrycyclodextrininflammation030220 oncology & carcinogenesisintestinal epithelial cells
researchProduct

Physicochemical Properties of A New PEGylated Polybenzofulvene Brush for Drug Encapsulation

2019

A new polymer brush was synthesized by spontaneous polymerization of benzofulvene macromonomer 6-MOEG-9-T-BF3k bearing a nona(ethylene glycol) side chain linked to the 3-phenylindene scaffold by means of a triazole heterocycle. The polymer structure was studied by SEC-MALS, NMR spectroscopy, and MALDI-TOF MS techniques, and the results supported the role of oligomeric initiatory species in the spontaneous polymerization of polybenzofulvene derivatives. The aggregation features of high molecular weight poly-6-MOEG-9-T-BF3k-FE were investigated by pyrene fluorescence analysis, dynamic light scattering studies, and transmission electron microscopy, which suggested a tendency towards the format…

lcsh:RS1-441Pharmaceutical ScienceAffinity polymerization; Drug delivery systems; Grafting through; Nanocarrier; PEGylation; Polybenzofulvene; Spontaneous polymerization02 engineering and technology010402 general chemistryPolymer brush01 natural sciencesArticlelcsh:Pharmacy and materia medicadrug delivery systemschemistry.chemical_compoundDynamic light scatteringSide chaindrug delivery systemchemistry.chemical_classificationaffinity polymerizationgrafting throughpolybenzofulvenePEGylationPolymer021001 nanoscience & nanotechnologyMacromonomer0104 chemical sciencesspontaneous polymerizationPolymerizationchemistryChemical engineeringPEGylation; grafting through; polybenzofulvene; nanocarrier; drug delivery systems; spontaneous polymerization; anity polymerizationDrug deliverynanocarrier0210 nano-technologyEthylene glycolPharmaceutics
researchProduct

Anti-tumor activity of the methanolic extracts of Salvia menthifolia

2012

In the present research we investigated the anti-proliferative activity of Salvia menthifolia Ten. (formerly Salvia menthaefolia), Lamiaceae, on a glioblastoma cell line, since up to date poor therapeutic results have been reported for treatment of malignant glioblastoma. Methanol extracts from different anatomical parts of S. menthifolia were tested on DBTRG-05MG cell line by MTT assay. The most active primary stems extract was also evaluated for apoptosis induction. Results confirmed the anti-tumor property of all the organs and demonstrated that the primary stems extract induced apoptosis after 4 h with the highest values of DNA fragmentation after 6 to 24 h. Some extracts were also HPLC…

lcsh:RS1-441Salvialcsh:Pharmacy and materia medicachemistry.chemical_compoundapoptosis glioblastoma Salvia menthifolia sageCaffeic acidMTT assaySettore BIO/15 - Biologia FarmaceuticaGeneral Pharmacology Toxicology and Pharmaceuticsapoptosis; glioblastoma; Salvia menthifolia; sageapoptosis glioblastomabiologyTraditional medicineRosmarinic acidapoptosisglioblastomaSalvia menthifoliabiology.organism_classificationQuercitrinSettore CHIM/08 - Chimica FarmaceuticasagechemistryBiochemistryPolyphenolSettore BIO/03 - Botanica Ambientale E ApplicataDNA fragmentationLamiaceae
researchProduct

Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study

2021

Sexual dysfunctions in people with schizophrenia are more severe than in the general population and are an important element in the treatment of schizophrenia. The mechanism of sexual dysfunction in patients treated for schizophrenia may be related to the side effects of antipsychotic drugs (hyperprolactinemia, suppression of the reward system), but it may also be related to the pathogenesis of schizophrenia itself. The aim of the study was to present the possibility of using amantadine in the treatment of sexual dysfunction in schizophrenia without the concomitant hyperprolactinemia. In an open and naturalistic case series study, five men treated for schizophrenia in a stable mental state …

libidomedicine.medical_specialtymedicine.medical_treatmentPopulationantipsychotic drugsPharmaceutical SciencePharmacy and materia medicahyperprolactinemiaDrug Discoverymental disordersMedicineeducationAntipsychoticPsychiatryLibidoeducation.field_of_studyamantadinesex drivebusiness.industryCommunicationatypical antipsychoticsAmantadineRmedicine.diseasesexual disfunctionsRS1-441schizophreniaSexual desireSexual dysfunctionSchizophreniaMolecular MedicineMedicinemedicine.symptombusinessCase seriesmedicine.drugPharmaceuticals
researchProduct

Survey of condition of light and humidity microclimate in some work and/or study areas

2012

light and humidity microclimate and occupational healthSettore MED/44 - Medicina Del Lavoro
researchProduct

Sulla problematica esistenza delle parole

2009

linguaggio Chomsky470 Latin & Italic languages460 Spanish & Portuguese languages410 Linguistics450 Italian Romanian & related languages800 Literature rhetoric & criticismSettore L-LIN/01 - Glottologia E Linguistica440 French & related languages10103 Institute of Romance Studies
researchProduct

Relazioni e differenze: questioni di linguistica razionale

2011

linguistica470 Latin & Italic languages460 Spanish & Portuguese languages410 Linguistics450 Italian Romanian & related languages800 Literature rhetoric & criticism440 French & related languages10103 Institute of Romance Studies
researchProduct

Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications

2019

In the last years the rapid development of Nucleic Acid Based Drugs (NABDs) to be used in gene therapy has had a great impact in the medical field, holding enormous promise, becoming “the latest generation medicine” with the first ever siRNA-lipid based formulation approved by the United States Food and Drug Administration (FDA) for human use, and currently on the market under the trade name Onpattro™. The growth of such powerful biologic therapeutics has gone hand in hand with the progress in delivery systems technology, which is absolutely required to improve their safety and effectiveness. Lipid carrier systems, particularly liposomes, have been proven to be the most su…

liposomes0303 health sciencesclinical trialsNABDsComputer sciencelcsh:RS1-441Pharmaceutical Science02 engineering and technologyLimitingReview021001 nanoscience & nanotechnologylcsh:Pharmacy and materia medicaClinical trialFood and drug administration03 medical and health sciencesHuman useRisk analysis (engineering)siRNAProduction (economics)NABDs; SiRNA; Liposomes; Clinical trials0210 nano-technology030304 developmental biologyPharmaceutics
researchProduct